Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-101 in Dermatosis Papulosa Nigra
NCT03224598Phase 2Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Jun 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide gel in dermatosis papulosa nigra (DPN), sponsored by Aclaris Therapeutics, Inc.. Started Jun 2017; status: completed.
02
Drugs
hydrogen peroxide gel
03
Conditions
dermatosis papulosa nigra (DPN)
Beyond the preview
Go deeper on NCT03224598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03224598.